跳至主要内容
临床试验/NCT00584155
NCT00584155撤回1 期

Evaluation of Lactated Ringers for Protection From Cisplatin Ototoxicity.

University of Oklahoma1 个研究点 分布在 1 个国家开始时间: 2006年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
撤回
试验地点
1
主要终点
Pre-treatment audiogram will be compared with the post treatment audiogram. The differences between the two will be calculated and compared to the differences in the opposite ear.

研究概览

简要总结

The purpose of this study is to determine if Lactated Ringer's solution is effective in patients undergoing chemotherapy with cisplatin for head and neck cancer in regards to cisplatin-induced hearing loss.

详细描述

About one-third of people who have been given Cisplatin, as part of their chemotherapy treatment, develop hearing loss. The purpose of this study is to determine if some degree of hearing loss can be prevented by use of Lactated Ringer's solution in the middle ear. To study this, patients will use drops in their ears; Lactated Ringer's will be placed in one ear and an inactive saline solution will be placed in the other. Ofloxacin, an eardrop antibiotic will be placed in each ear at the same time. Each participant will receive a hearing evaluation before each dose of Cisplatin and another evaluation 2 to 4 weeks after the final treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with cancer to be treated with cisplatin.
  • Patients expected to receive a minimum of 3 rounds of chemotherapy.
  • Patients receiving a minimum dose of cisplatin of 70 mg/m2

排除标准

  • Patients who have had middle ear surgery.
  • Patients who have active external or middle ear disease
  • Patients who have preceding pure tone average of >40 dB HL

研究组 & 干预措施

1

Placebo Comparator

Each patient will receive a bottle containing normal saline and 0.03% ofloxacin.

干预措施: Normal Saline and 0.3% ofloxacin (Drug)

2

Experimental

Each patient will receive a bottle containing Lactated Ringer's solution and 0.03% ofloxacin.

干预措施: Lactated Ringer's with 0.03% Ofloxacin (Drug)

结局指标

主要结局

Pre-treatment audiogram will be compared with the post treatment audiogram. The differences between the two will be calculated and compared to the differences in the opposite ear.

时间窗: Patients will be enrolled in the study for 4-6 weeks from the initiation of therapy

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dini Chissoe

Study Coordinator

University of Oklahoma

研究点 (1)

Loading locations...

相似试验